August 24, 2009 – The nuclear reactor in Petten, The Netherlands, which supplies medical isotopes, is up and running again after a scheduled maintenance.
Covidien (COV.N) expects to begin receiving material from the reactor in Petten this weekend, the company said in a letter to hospital clients dated August 18 and posted on the U.S. Food and Drug Administration website on Thursday.
Covidien gets most of its isotopes from the reactor, processes the raw material known as molybdenum-99 or Mo 99, used for diagnostic imaging tests.
For more information: www.covidien.com